These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 35612697

  • 21. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT, Maranhão RC, Tavares ER, Carvalho PO, Higuchi ML, Mattos FR, Pitta FG, Hatab SA, Kalil-Filho R, Serrano CV.
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
    [Abstract] [Full Text] [Related]

  • 22. Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel.
    Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhão RC.
    J Pharm Pharmacol; 2002 Jun; 54(6):765-72. PubMed ID: 12078992
    [Abstract] [Full Text] [Related]

  • 23. Metabolic behavior in rats of a nonprotein microemulsion resembling low-density lipoprotein.
    Maranhão RC, Cesar TB, Pedroso-Mariani SR, Hirata MH, Mesquita CH.
    Lipids; 1993 Aug; 28(8):691-6. PubMed ID: 8377582
    [Abstract] [Full Text] [Related]

  • 24. Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors.
    Maranhão RC, Roland IA, Toffoletto O, Ramires JA, Gonçalves RP, Mesquita CH, Pileggi F.
    Lipids; 1997 Jun; 32(6):627-33. PubMed ID: 9208392
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits.
    Bulgarelli A, Leite AC, Dias AA, Maranhão RC.
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):531-9. PubMed ID: 24065615
    [Abstract] [Full Text] [Related]

  • 30. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.
    Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino-Filho AT, Pinto IM, Maranhão RC.
    Clinics (Sao Paulo); 2016 Aug; 71(8):435-9. PubMed ID: 27626473
    [Abstract] [Full Text] [Related]

  • 31. Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.
    Tavares ER, Freitas FR, Diament J, Maranhão RC.
    Int J Nanomedicine; 2011 Aug; 6():2297-304. PubMed ID: 22072867
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats.
    Maranhão RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD, Nicolau JC, Salemi VM, Kalil-Filho R.
    Int J Nanomedicine; 2017 Aug; 12():3767-3784. PubMed ID: 28553113
    [Abstract] [Full Text] [Related]

  • 34. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.
    Contente TC, Kretzer IF, Filippin-Monteiro FB, Maria DA, Maranhão RC.
    J Pharm Pharmacol; 2014 Dec; 66(12):1698-709. PubMed ID: 25131262
    [Abstract] [Full Text] [Related]

  • 35. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy.
    Mendes S, Graziani SR, Vitório TS, Padoveze AF, Hegg R, Bydlowski SP, Maranhão RC.
    Gynecol Oncol; 2009 Feb; 112(2):400-4. PubMed ID: 19062081
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gene Therapy Based on Lipid Nanoparticles as Non-viral Vectors for Glioma Treatment.
    Luiz MT, Tofani LB, Araújo VHS, Di Filippo LD, Duarte JL, Marchetti JM, Chorilli M.
    Curr Gene Ther; 2021 Feb; 21(5):452-463. PubMed ID: 33390137
    [Abstract] [Full Text] [Related]

  • 39. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.
    Teixeira RS, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC.
    J Pharm Pharmacol; 2008 Oct; 60(10):1287-95. PubMed ID: 18812021
    [Abstract] [Full Text] [Related]

  • 40. Plasma kinetics of an LDL-like nanoemulsion and lipid transfer to HDL in subjects with glucose intolerance.
    Bertato MP, Oliveira CP, Wajchenberg BL, Lerario AC, Maranhão RC.
    Clinics (Sao Paulo); 2012 Oct; 67(4):347-53. PubMed ID: 22522760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.